Haglund C - Search Results

1

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread.

Vesterinen T, Kuopio T, Ahtiainen M, Knuuttila A, Mustonen H, Salmenkivi K, Arola J, Haglund C. Vesterinen T, et al. Among authors: haglund c. Endocr Connect. 2019 Aug 1;8(8):1168-1175. doi: 10.1530/EC-19-0308. Endocr Connect. 2019. PMID: 31299636 Free PMC article.

2

Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.

Salmenkivi K, Arola J, Voutilainen R, Ilvesmäki V, Haglund C, Kahri AI, Heikkilä P, Liu J. Salmenkivi K, et al. Among authors: haglund c. J Clin Endocrinol Metab. 2001 May;86(5):2231-5. doi: 10.1210/jcem.86.5.7446. J Clin Endocrinol Metab. 2001. PMID: 11344232

3

Increased expression of tenascin in pheochromocytomas correlates with malignancy.

Salmenkivi K, Haglund C, Arola J, Heikkilä P. Salmenkivi K, et al. Among authors: haglund c. Am J Surg Pathol. 2001 Nov;25(11):1419-23. doi: 10.1097/00000478-200111000-00010. Am J Surg Pathol. 2001. PMID: 11684959

4

Increased expression of cyclooxygenase-2 in malignant pheochromocytomas.

Salmenkivi K, Haglund C, Ristimäki A, Arola J, Heikkilä P. Salmenkivi K, et al. Among authors: haglund c. J Clin Endocrinol Metab. 2001 Nov;86(11):5615-9. doi: 10.1210/jcem.86.11.8052. J Clin Endocrinol Metab. 2001. PMID: 11701743

5

VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.

Salmenkivi K, Heikkilä P, Liu J, Haglund C, Arola J. Salmenkivi K, et al. Among authors: haglund c. APMIS. 2003 Apr;111(4):458-64. doi: 10.1034/j.1600-0463.2003.1110402.x. APMIS. 2003. PMID: 12780519

6

Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas.

Salmenkivi K, Heikkilä P, Haglund C, Louhimo J, Arola J. Salmenkivi K, et al. Among authors: haglund c. Histopathology. 2003 Jul;43(1):62-71. doi: 10.1046/j.1365-2559.2003.01645.x. Histopathology. 2003. PMID: 12823714

7

Malignancy in pheochromocytomas.

Salmenkivi K, Heikkilä P, Haglund C, Arola J. Salmenkivi K, et al. Among authors: haglund c. APMIS. 2004 Sep;112(9):551-9. doi: 10.1111/j.1600-0463.2004.apm1120901.x. APMIS. 2004. PMID: 15601303 Review.

8

Frequent loss of heterozygosity at 6q in pheochromocytoma.

Lemeta S, Salmenkivi K, Pylkkänen L, Sainio M, Saarikoski ST, Arola J, Heikkilä P, Haglund C, Husgafvel-Pursiainen K, Böhling T. Lemeta S, et al. Among authors: haglund c. Hum Pathol. 2006 Jun;37(6):749-54. doi: 10.1016/j.humpath.2006.02.002. Hum Pathol. 2006. PMID: 16733217

9

Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat.

Cederqvist K, Janer J, Tervahartiala T, Sorsa T, Haglund C, Salmenkivi K, Stenman UH, Andersson S. Cederqvist K, et al. Among authors: haglund c. Pediatr Res. 2006 Oct;60(4):395-400. doi: 10.1203/01.pdr.0000238342.16081.f9. Epub 2006 Aug 28. Pediatr Res. 2006. PMID: 16940237

10

High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma.

Häyry V, Salmenkivi K, Arola J, Heikkilä P, Haglund C, Sariola H. Häyry V, et al. Among authors: haglund c. Endocr Relat Cancer. 2009 Dec;16(4):1211-8. doi: 10.1677/ERC-09-0049. Epub 2009 Jul 29. Endocr Relat Cancer. 2009. PMID: 19641025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters